• Title/Summary/Keyword: VMTH-SNU

Search Result 5, Processing Time 0.021 seconds

Acute Temporary Visual Loss after General Anesthesia in a Cat (전신 마취 후 발생한 고양이의 일시적인 급성 시력상실 1례)

  • Son, Won-Gyun;Jung, Bo-Young;Kwon, Tae-Eog;Seo, Kang-Moon;Lee, In-Hyung
    • Journal of Veterinary Clinics
    • /
    • v.26 no.5
    • /
    • pp.480-482
    • /
    • 2009
  • A 2-year-old, castrated male, Scottish fold cat was referred to Veterinary Medical Teaching Hospital of Seoul National University (VMTH-SNU) for evaluation of acute bilateral blindness after general anesthesia. For dental prophylaxis in local animal hospital, general anesthesia had been induced with intravenous acepromazine and ketamine, and maintained with isoflurane after intubation. At VMTH-SNU on next day, complete blood count, electrolytes and serum chemistry values were within normal ranges. On neurologic examination, visual placing and postural reactions like as hopping, hemiwalking and wheelborrowing were reduced on right hindlimb. On ophthalmic examination, menace responses were absent on both eyes and pupillary light reflex (PLR) reduced on right eye, but other reflex and fundus were normal. Prednisolone (2 mg/kg sid for 3 days) was administrated orally and tapered. Visual placing was possible on 2nd day, and postural reactions were recovered on 4th day after dental prophylaxis. Based on the process and recovery, this case was considered as postoperative visual loss (POVL) after general anesthesia.

Recombinant Tissue Plasminogen Activator Therapy for Aortic Thromboembolism in Four Dogs

  • Han, Sei-Myoung;Lee, Ji-Ye;Kweon, Kyeong;Choi, Min-Cheol;Yoon, Jung-Hee;Youn, Hwa-Young
    • Journal of Veterinary Clinics
    • /
    • v.33 no.3
    • /
    • pp.155-159
    • /
    • 2016
  • Four dogs were brought to the Veterinary Medicine Teaching Hospital of Seoul National University (VMTH SNU) with a history of hind limb ataxia, three with pain, one without pain. Three of the four showed weak to absent femoral pulses and cold extremities. Thromboembolism was identified by ultrasonography in the external and/or internal iliac arteries. A thrombolytic agent, recombinant tissue plasminogen activator (rt-PA), was administered (0.5-1 mg/kg, every 60-120 min, 3-5 doses). Two dogs (Cases 2 and 3), which were instantly provided rt-PA treatment, survived 6 and 17 months, respectively, although hematemesis and hematochezia were observed during treatment. In the other two dogs (Cases 1 and 4), rt-PA was administered 4 and 28 days after the appearance of pelvic limb symptoms, which may have limited the benefits of the treatment. When rt-PA treatment is instituted instantly and the side effects are monitored thoroughly during treatment, a good prognosis might be expected in canine aortic thromboembolism. For this reason, we suggest that rt-PA treatment should be initiated immediately if thromboembolism is identified.

Outcome of Pars Plana Retinopexy with Perfluoro-n-octane-Silicone Oil Exchange for Rhegmatogenous Retinal Detachment in Dogs: 9 Eyes

  • Susanti, Lina;Kang, Seonmi;Park, Sangwan;Park, Eunjin;Park, Yoonji;Kim, Boyun;Jeong, Manbok;Seo, Kangmoon
    • Journal of Veterinary Clinics
    • /
    • v.35 no.4
    • /
    • pp.126-129
    • /
    • 2018
  • This study was performed to describe the outcome of pars plana retinopexy with perfluoro-n-octane (PFO)-silicone oil (SiO) exchange in dogs with rhegmatogenous retinal detachment in Seoul National University Veterinary Medical Teaching Hospital (SNU VMTH) from 2014 to 2017. Nine eyes of 8 dogs were included in this study. Medical records including signalment, history, duration from onset of blindness to surgical intervention, pre-operative findings, duration from surgery to regaining vision, and post-operative complications were evaluated. No eyes were visual before surgery. Duration from onset of blindness to surgical intervention was 2-30 days (median 8 days); duration from surgery to regain vision was 1-14 days (median 6 days); follow-up time was 15-1088 days (median 69 days). Post-operative complications were divided as temporary vs permanent conditions. Temporary complications were corneal ulcer, uveitis, retinal haemorrhage, glaucoma, subconjunctival leakage of SiO, and vitreal haemorrhage. Permanent complications were anterior chamber migration of SiO, retinal degeneration, corneal degeneration, re-detachment, and cataract. Six of 9 eyes regained functional vision, five of which remained visual throughout the follow-up time while the other one lost vision after 3 months because of uveitic glaucoma. In conclusion, pars plana retinopexy with PFO-SiO exchange provided fair outcome in 66.7% cases described in this study.

A Retrospective Study of Primary Glaucoma in Dogs: 43 cases (2006 ~ 2009) (개에서 발생한 원발성 녹내장 43례 (2006 ~ 2009))

  • Park, Young-Woo;Jeong, Man-Bok;Park, Shin-Ae;Kim, Won-Tae;Kim, Se-Eun;Ahn, Jae-Sang;Seo, Kang-Moon
    • Journal of Veterinary Clinics
    • /
    • v.29 no.1
    • /
    • pp.38-42
    • /
    • 2012
  • To determine the prevalence of the primary glaucoma (PG) and occurrence of primary glaucoma in initially non-affected normal eye. Medical records of 7751 dogs presented to the Veterinary Medical Teaching Hospital (VMTH) of Seoul National University (SNU) between January 2006 and December 2009 were examined. Among 7751 dogs, forty three dogs (0.55%) developed PG. The following breeds were included in the study: 18 American Cocker Spaniels, 17 Shih Tzus, 3 Mixed Breeds, 2 Malteses, 2 Pekingeses, and 1 Chow Chow. The mean onset age of PG in the first eyes was $7.1{\pm}2.3$ years in the all breeds. Compared with Mixed Breed (0.54%), American Cocker Spaniel (3.16%, p = 0.004) and Chow Chow (20%, p = 0.001) had a higher risk of developing glaucoma. Twenty six of 43 dogs (60.1%) were females with male-to-female ratio of 1:1.53. Twenty nine of 33 eyes (87.9%) developed glaucoma in the fellow eye within mean ${\pm}SD$ time of $17.5{\pm}2.7$ months. From this study, American Cocker Spaniel and Shih Tzu were the most frequent PG breed in Korea. Also, unilateral PG dogs developed glaucoma in the non-affected normal eye within approximately 17 months. The results indicate that prophylactic medical therapy with antiglaucoma agents should be considered to delay or prevent developing glaucoma in non-affected normal eye.